Simplex Trading, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Simplex Trading, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$0.22 - $0.42 $957 - $1,828	-4,354 Reduced 79.11%	1,150 $0
Q2 2024 Jul 25, 2024	BUY	$0.34 - $0.74 $498 - $1,084	1,465 Added 36.27%	5,504 $1,000
Q1 2024 Apr 25, 2024	BUY	$0.28 - $0.66 $1,130 - $2,665	4,039 New	4,039 $2,000
Q1 2023 Apr 27, 2023	BUY	$1.43 - $3.3 $246,449 - $568,728	172,342 Added 1559.94%	183,390 $605,000
Q4 2022 Feb 02, 2023	BUY	$1.37 - $4.42 $14,861 - $47,948	10,848 Added 5424.0%	11,048 $18,000
Q2 2022 Aug 03, 2022	SELL	$2.71 - $3.6 $5,902 - $7,840	-2,178 Reduced 91.59%	200 $0
Q1 2022 May 02, 2022	BUY	$2.92 - $4.19 $6,359 - $9,125	2,178 Added 1089.0%	2,378 $7,000
Q4 2020 Feb 02, 2021	SELL	$3.99 - $17.73 $2,793 - $12,411	-700 Reduced 77.78%	200 $0
Q3 2020 Oct 14, 2020	BUY	$11.19 - $16.92 $10,071 - $15,228	900 New	900 $15,000
Q3 2019 Oct 15, 2019	SELL	$3.54 - $4.48 $56,565 - $71,585	-15,979 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$3.59 - $4.3 $41,267 - $49,428	11,495 Added 256.36%	15,979 $63,000
Q1 2019 Apr 18, 2019	BUY	$3.37 - $4.34 $7,535 - $9,704	2,236 Added 99.47%	4,484 $0
Q4 2018 Jan 16, 2019	BUY	$2.98 - $3.9 $6,216 - $8,135	2,086 Added 1287.65%	2,248 $7,000
Q3 2018 Oct 23, 2018	SELL	$3.73 - $4.38 $10,190 - $11,966	-2,732 Reduced 94.4%	162 $0
Q2 2018 Jul 30, 2018	BUY	$3.12 - $5.19 $7,347 - $12,222	2,355 Added 436.92%	2,894 $11,000
Q1 2018 Apr 26, 2018	SELL	$3.01 - $3.77 $1,622 - $2,032	-539 Reduced 50.0%	539 $1,000
Q4 2017 Jan 10, 2018	BUY	$2.96 - $4.42 $3,190 - $4,764	1,078	1,078 $4,000

549K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $56.2M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.